Matthew
Levesque.

What he's doing right now

On December 23, 2025, IntelyCare closed its acquisition of CareRev. The two companies had been circling each other for years — both build shift-based marketplaces for hospital nurses, both raised a lot of money in the pandemic-era boom, both watched the rate cards deflate afterward. Matthew Levesque, IntelyCare's CEO since July 2024, will run the combined thing. Announcing it, he offered the kind of quote you would expect from a marketplace operator who has done this before: "By bringing IntelyCare and CareRev together, we're creating a more integrated and reliable way for facilities to manage permanent staff, internal resource pools, and contingent labor through a single tech platform."

Read that sentence twice. Permanent staff. Internal resource pools. Contingent labor. Single tech platform. That is not a per-diem app. That is a workforce management system that just happens to have started life as a per-diem app. This is the pivot Levesque signaled when he took the job eighteen months earlier — the plan to expand IntelyCare into what the press release called a "total talent solution" across acute and post-acute care. The CareRev deal is the mechanism.

The strange part is that Levesque has been on the other side of this equation before. Between roughly 2020 and 2022 he was CEO of connectRN, which is the company most industry people would name in the same breath as IntelyCare and CareRev when listing the three most-cited platforms in shift-based nurse labor. He is now the only publicly known executive to have run two of those three companies, and to have bought the third.

The core of what we do at IntelyCare is putting nurses by the bedside where they are most needed.Matthew Levesque, on taking the CEO role, July 2024

The resume, in the correct order

The temptation with any healthcare-executive profile is to lead with athenahealth. Resist. Start with the priceline.com job, because it is the only one that is genuinely surprising. In the early 2000s, Levesque worked in operating roles at William Shatner-era Priceline — the "Name Your Own Price" phase, where the fundamental business problem was matching unpredictable inventory to unpredictable demand at a variable price. This is, of course, also the fundamental business problem of nurse per-diem staffing. He did not know it at the time. But the muscle got built.

Then came a long detour into healthcare's payer side: Oxford Health Plans, Harvard Pilgrim Health Care. Both are Northeastern insurers. Neither is famous for making anyone rich, but both are famous for teaching operators how U.S. healthcare gets billed, which is a career-long tuition payment nobody takes voluntarily.

Then twelve years at athenahealth. This is the load-bearing period of the CV. Athenahealth was the great Boston healthtech story of the 2010s: a cloud-based physician billing and records company that grew, as noted in every press release about Levesque, from $100 million in revenue to $1.3 billion. He rose to Senior Vice President of Technology Enabled Services. In practical terms this means he ran the humans who did the work that the software could not, and figured out where to draw the line between the two — a job that has essentially no non-healthcare equivalent, and is now the most valuable skill he brings to IntelyCare.

Groups, and the value-based interlude

After connectRN, and before IntelyCare, Levesque spent time as President and COO of Groups Recover Together, which is the value-based opioid-treatment company. This is not the kind of pit-stop that lands in a marketplace-operator's story neatly. But it fits the pattern: another mission-driven business, another two-sided problem — patients on one side, clinicians and treatment programs on the other, with reimbursement dynamics running through the middle. The lesson from Groups, insofar as one is ever articulated, is what a company looks like when the stakes of the match are life and death. IntelyCare talks a lot about facility "shift attendance" and "reliability improvement." Levesque, having spent time inside opioid recovery, is unusually well positioned to know why "reliability" is not a KPI dashboard word.

What his coworkers keep saying about him

Search for Levesque's name in press coverage and you get the same phrase back, in various rewordings: "veteran healthcare executive known for scaling mission-driven organizations." The IntelyCare board used it. So did the Groups Recover Together announcement. So did connectRN's own hiring post in 2020. It is corporate language, but it is also unusually consistent, and consistent language across independent sources usually reflects an actual reputation. In this case: someone who is trusted to take mid-stage healthcare companies and get them across the harder revenue milestones without breaking what made them worth funding.

The map of the career

Quincy, and the geography of the company

IntelyCare's headquarters sit at 1250 Hancock Street in Quincy, Massachusetts, which is not the Kendall Square you would expect for a Series C healthtech. Quincy is a working South Shore city with a granite-industry past and a substantial healthcare presence — hospitals, long-term care, home health — the actual demand side of the marketplace Levesque runs. The address block is a short walk from the John Adams birthplace. This is either fitting or coincidence, depending on how much you enjoy that sort of thing.

The company reports roughly 2,200 employees, annual revenue around $509 million, and, per its own marketing, more than a million registered nursing professionals on the platform. Total funding to date sits at $173.8 million, with the last major round — a Series C of $115 million — closing in April 2022, before Levesque arrived. He inherited the balance sheet; he wrote the acquisition.

The tech stack, minus the AI marketing

The company's press materials lean heavily on phrases like "AI-driven shift matching" and "machine learning" and "data-driven staffing." The actual observable stack — the tools IntelyCare pays for — reads more like a well-run growth-stage B2B company than a research lab: Salesforce, Marketo, Zendesk, Slack, Jobvite, Lever, Google Tag Manager, Amazon Route 53. There is a mobile app, on iOS and Google Play, that is the actual product surface for most nurses. AI is presumably somewhere inside the matching engine. But no one at IntelyCare has yet claimed to have rewritten the company around a foundation model, and Levesque, from his athenahealth years, is unlikely to be the executive who does so for fashion.

Nurses don't quit nursing. They quit schedules. IntelyCare, at its most reduced, is a bet that if you fix the second problem, you keep more of the first.

The market, and why anyone should care

American nursing has a demographic problem that no amount of software will fix. Boomers age; nursing schools graduate approximately the same number of students they did in 2019. Hospitals and post-acute facilities compete for the same finite pool of clinicians, which means the marginal shift becomes the entire game. Per-diem platforms exist to clear those marginal shifts efficiently, and they proliferated wildly during COVID because the rate cards were spectacular. The rate cards have since deflated. What remains is a real, structural, non-going-away market for shift-based labor, but at less exciting margins.

Consolidation in that market is therefore not surprising. What is surprising is who did the consolidating. CareRev had, at various points, been treated as the more Silicon Valley-flavored of the platforms, with West Coast investors and a slicker consumer aesthetic. IntelyCare, from Quincy, has always looked more workmanlike. The workmanlike one bought the slicker one. That is a data point.

The education footnote

Levesque holds a Bachelor of Science in Finance from Siena College, a small liberal arts institution in Loudonville, New York, outside Albany. Siena's finance department is not a well-worn pipeline to Boston healthtech CEO chairs. It is a pipeline to regional banking, insurance, and public accounting. Levesque took the longer road.

What comes next

Integrating CareRev is the next twelve months, minimum. Beyond that, the stated ambition is to expand IntelyCare into permanent hiring — full-time and part-time nursing placements at the same facilities the platform already services on the shift side. If that works, IntelyCare stops being a staffing agency's software competitor and starts being an HRIS competitor for a specific vertical, which is a substantially larger prize. If it does not work, the company will settle in as one of the two or three players any hospital VP of nursing has to at least consider on an RFP.

Either outcome would be a reasonable result. Levesque is not the founder of IntelyCare. He is the operator brought in to make the company's second act sensible, and he is doing what operators brought in for that reason usually do: buying, integrating, and quietly rewriting the strategy deck.

Frequently Asked